Patents by Inventor Guy Marchal

Guy Marchal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8741262
    Abstract: The present invention concerns a therapeutically labeled napthodianthrone or phenanthro[1,10,9,8-opqra]perylene-7,14-dione compound, which comprises a chemical element or an isotope that has an unstable nucleus and emits radiation during its decay to a stable form sufficient to destroy neighboring cells or tissues for use in a targeted radiotherapy to enhance curability of a warm-blooded animal that has been subjected to a necrosis-inducing antitumor therapy. A particular advantage of present invention is that viable rim resistant to a necrosis-inducing antitumor therapy such as vascular targeting agent (VTA) can be supplemented by one single or repeated doses of a therapeutically radiolabeled small molecule necrosis-avid chemical compound treatment to enhance the curability.
    Type: Grant
    Filed: November 26, 2008
    Date of Patent: June 3, 2014
    Assignee: Katholieke Universiteit Leuven, K.U. Leuven R&D
    Inventors: Yicheng Ni, Marie Van De Putte, Peter DeWitte, Alfons Verbruggen, Guy Marchal, Ziping Sun
  • Publication number: 20110038795
    Abstract: The present invention concerns a therapeutically labeled napthodianthrone or phenanthro[1,10,9,8-opqra]perylene-7,14-dione compound, which comprises a chemical element or an isotope that has an unstable nucleus and emits radiation during its decay to a stable form sufficient to destroy neighboring cells or tissues for use in a targeted radiotherapy to enhance curability of a warm-blooded animal that has been subjected to a necrosis-inducing antitumor therapy. A particular advantage of present invention is that viable rim resistant to a necrosis-inducing antitumor therapy such as vascular targeting agent (VTA) can be supplemented by one single or repeated doses of a therapeutically radiolabeled small molecule necrosis-avid chemical compound treatment to enhance the curability.
    Type: Application
    Filed: November 26, 2008
    Publication date: February 17, 2011
    Applicant: KATHOLIEKE UNIVERSITEIT LEUVEN K.U.LEUVEN R&D
    Inventors: Yicheng Ni, Marie Van De Putte, Peter De Witte, Alfons Verbruggen, Guy Marchal, Ziping Sun
  • Publication number: 20090274622
    Abstract: The invention relates to a method for obtaining an image of ischemic, infarcted or necrotic tissue in a subject, comprising the step of administering an imaging agent comprising a phenanthro[1,10,9,8-opqra]perylene-7,14-dione compound. For example, the invention concerns to the use of phenanthro[1,10,9,8-opqra]perylene-7,14-dione derivatives, and more specifically hypericin or its derivatives, as necrosis or infarct specific agents. The phenanthro[1,10,9,8-opqra]perylene-7,14-dione derivatives can be labeled with a radionuclide, a radiopaque material or a material enhancing the effects magnetic resonance imaging. The invention further features a pharmaceutical composition comprising a phenanthro[1,10,9,8-opqra]perylene-7,14-dione compound optionally conjugated to a radionuclide or a radiopaque material, provided that said phenanthro[1,10,9,8-opqra]perylene-7,14-dione compound is not mono-[123I]-iodohypericin.
    Type: Application
    Filed: July 13, 2009
    Publication date: November 5, 2009
    Applicant: K.U. Leuven Research & Development
    Inventors: Ni YICHENG, Guy Bormans, Guy Marchal, Alfons Verbruggen
  • Publication number: 20070122340
    Abstract: The present invention concerns to the use of phenanthro[1,10,9,8-opqra]perylene-7,14-dione derivatives, and more specifically hypericin or its derivatives, as necrosis or infarct specific agents. The phenanthro[1,10,9,8-opqra]perylene-7,14-dione derivatives can be labeled with a radionuclide, a radiopaque material or a material enhancing the effects magnetic resonance imaging.
    Type: Application
    Filed: July 23, 2004
    Publication date: May 31, 2007
    Inventors: Ni Yicheng, Guy Bormans, Guy Marchal, Alfons Verbruggen
  • Patent number: 7081472
    Abstract: Metal-complexable substituted bis-indole derivatives comprising the structure shown in formula (I) hereunder: enantiomers and pharmaceutically acceptable salts thereof and metal complexes thereof, wherein L, R1, R2, R3, C1, C2, m, n, p, q and r are as defined in claim 1 for use as constrats agents.
    Type: Grant
    Filed: November 7, 2001
    Date of Patent: July 25, 2006
    Assignee: K. U. Leuven Research & Development
    Inventors: Erwin Cresens, Yicheng Ni, Paul Adriaens, Alfons Verbruggen, Guy Marchal
  • Publication number: 20040053911
    Abstract: Metal-complexable substituted bis-indole derivatives comprising the structure shown in formula (I) hereunder: enantiomers and pharmaceutically acceptable salts thereof and metal complexes thereof, wherein L, R1, R2, R3, C1, C2, m, n, p, q and r are as defined in claim 1 for use as constrats agents.
    Type: Application
    Filed: October 23, 2003
    Publication date: March 18, 2004
    Inventors: Erwin Cresens, Yicheng Ni, Paul Adriaens, Alfons Verbruggen, Guy Marchal
  • Patent number: 6514251
    Abstract: Device for delivering radio frequency (RF) energy, for example during tissue ablation procedures, comprising an electrode having a distal end associated with tissue puncturing means and a proximal end connectable to a radio frequency energy source, wetting means for wetting the proximity of the distal end of the electrode with a non-toxic (RF) conductive solution and cooling means for cooling at least the distal end of the electrode. The invention further relates to a process for cooling and wetting a radio frequency energy delivering device and to a guidance element therefor.
    Type: Grant
    Filed: May 1, 2001
    Date of Patent: February 4, 2003
    Assignee: K.U. Leuven Research & Development
    Inventors: Yicheng Ni, Yi Miao, Guy Marchal
  • Patent number: 6273606
    Abstract: An assembly for recording a radiation image of an elongate body comprises a plurality of cassettes each conveying a recording member and each having a length that is smaller than the length of the elongate body. Supporting devices are arranged for holding the plurality of cassettes in a staggered arrangement so that the length of the staggered arrangement is at least equal to the length of the elongate body. This assembly is exposed to the radiation image of an elongate body. By use of partial images which are read from each of the recording members, the entire image of the elongate body is reconstructed.
    Type: Grant
    Filed: December 1, 1998
    Date of Patent: August 14, 2001
    Assignee: Agfa-Gevaert
    Inventors: Piet Dewaele, Piet Vuylsteke, Guy Marchal, Herman Pauwels